September 20, 2014 9:48 PM ET

Company Overview of Moffitt Cancer Center

Company Overview

Moffitt Cancer Center is based in the United States.


United States

Key Executives for Moffitt Cancer Center

Chief Operating Officer
Chief Nursing Officer and Vice President
Chief Health Information Officer and Vice President
Compensation as of Fiscal Year 2014.

Moffitt Cancer Center Key Developments

Rosetta Genomics Ltd. and Moffitt Cancer Center Enter into Strategic Alliance to Develop Microrna-Based Cancer Diagnostics

Rosetta Genomics Ltd. announced that the company has entered into a strategic alliance with Moffitt Cancer Center to discover, develop and commercialize a variety of microRNA-based cancer diagnostics. The three-year alliance brings together the resources and talents of Moffitt with those of Rosetta Genomics to stimulate new projects and collaborations for the development of diagnostics in areas of unmet medical need. Rosetta will provide funding for Moffitt investigator-initiated projects that align with Rosetta's strategic priorities. Rosetta has a proprietary discovery microarray platform with over 2,500 human microRNAs, along with a proprietary RT-PCR platform. Additionally, Rosetta has bioinformatics and microRNA wet lab expertise, with approximately 50 peer-reviewed publications across multiple cancers and other disease states and on many tissue types and body fluids. This strategic alliance will leverage Rosetta's capabilities and expertise.

Chris Sullivan Joins Moffitt Cancer Center Board of Advisors

Moffitt Cancer Center announced the appointment of Chris Sullivan to its national Board of Advisors. Sullivan founded Outback Steakhouse in 1988 with Bob Basham, Tim Gannon, and Trudy Cooper and served as former Chairman and CEO of Outback Steakhouse (OSI).

Rosetta and Moffitt Enter into Agreement to Develop Thyroid Neoplasia Assay

Rosetta Genomics Ltd. and Moffitt Cancer Center have entered into an agreement for the development and commercialization of Rosetta's thyroid neoplasia assay. Under the agreement, Rosetta will work with Marino Leon, associate member of the Department of Anatomic Pathology at Moffitt. A fine needle aspiration (FNA), a non-surgical procedure used to obtain tissue for analysis by a pathologist, is the standard technique for detecting cancer.

Similar Private Companies By Industry

Company Name Region
Caithness Coso Funding Corp. United States
MCR Property Management Inc. United States
Stratus I INC United States
Canadian General Life Insurance United States
FEM Electric Association, Inc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Moffitt Cancer Center, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at